The autosomal dominant disease tuberous sclerosis (TSC) is caused by mutations in either TSC1 on chromosome 9q34, encoding hamartin, or TSC2 on chromosome 16p13.3, encoding tuberin. TSC is characterized by hamartomas that occur in many organs of aected patients and these have been considered to likely result from defects in proliferation control. Although the true biochemical functions of the two TSC proteins have not been clari®ed, a series of independent investigations demonstrated that modulated hamartin or tuberin expression cause deregulation of proliferation/cell cycle in human, rodent and Drosophila cells. In support of tuberin acting as a tumor suppressor, ectopic overexpression of TSC2 has been shown to decrease proliferation rates of mammalian cells. Furthermore, overexpression of TSC2 has been demonstrated to trigger upregulation of the cyclin-dependent kinase inhibitor p27. We report that three dierent naturally occurring and TSC causing mutations within the TSC2 gene elliminate neither the anti-proliferative capacity of tuberin nor tuberin's eects on p27 expression. For the ®rst time these data provide strong evidence that deregulation of proliferation and/or upregulation of p27 are not likely to be the primary/only mechanisms of hamartoma development in TSC. These results demand reassessment of previous hypotheses of the pathogenesis of TSC. Oncogene (2001) 20, 4904 ± 4909.
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Tuberous sclerosis (TSC) is an autosomal dominant phakomatosis with an estimated prevalence of about 1 in 6000 newborns. It is characterized by the occurence of mental retardation, epilepsy, and by the development of a spectrum of tumor-like growths, named hamartomas, of the brain, skin, kidneys, heart and other organs. Common clinical features are facial angio®bromas, renal angiomyolipomas, hypopigmented macules, cardiac rhabdomyomas, and cortical tubers and subependymal glial nodules in the brain. The greatest source of morbidity is the brain tumors, which cause seizures in 80 ± 90% of aected individuals, mental retardation in about half of aected individuals, and behavioral abnormalities (mostly autism) in over half of aected individuals (Gomez et al., 1999) . Two TSC genes have been identi®ed, TSC1 on chromosome 9q34 (The TSC1 Consortium, 1997) encoding a 130 kDa protein named hamartin and TSC2 (The European Chromosome 16 Tuberous Sclerosis Consortium, 1993) on chromosome 16p13.3 encoding a 200 kDa protein named tuberin. Published TSC mutations include large deletions/rearrangements and missense mutations for TSC2 and insertions, deletions, nonsense and splicing mutations in both genes (recently reviewed in Young and Povey, 1998; Cheadle et al., 2000) . Hamartin and tuberin can associate physically in vivo (Van Slegtenhorst et al., 1998; Plank et al., 1998; Nellist et al., 1999) . Tuberin has been reported to possess GTPase-accelerating protein (GAP) activity for the small molecular weight GTPase Rap1a (Wienecke et al., 1995) and for Rab5 aecting the control of endocytosis , to be involved in transcriptional regulation Henry et al., 1998) , and to aect the control of neuronal dierentiation (Soucek et al., 1998a) . Hamartin has been demonstrated to bind ezrin/radixin/moesin protein family members and to activate the Rho GTPase and actin ®bre assembly (Lamb et al., 2000) . Furthermore, both tuberin and hamartin are involved in the regulation of cellular proliferation, the only function so far demonstrated for both proteins. Overexpression and antisense-experiments in mammalian cells revealed that high levels of tuberin have negative eects on cell proliferation, whereas downregulation/loss of tuberin stimulates proliferation (Jin et al., 1996; Orimoto et al., 1996; Soucek et al., 1997 Soucek et al., , 1998b Pajak et al., 1997; Pasumarthi et al., 2000) . Gigas, a Drosophila homolog of TSC2, was reported to be involved in cell cycle control (Ito and Rubin, 1999) . High ectopic levels of hamartin have also been shown to negatively regulate cellular proliferation (Miloloza et Oncogene (2001) Benvenuto et al., 2000) . However, mutations in the TSC genes that are causally involved in the development of TSC in patients have not been investigated in relation to eects of hamartin or tuberin on cellular proliferation. Answering this question is required to clarify the relevance of the functions of the proteins for the development of the disease.
Tuberin has been proposed to harbor a leucin zipper region at amino acids 75 ± 107, coiled-coil structures at amino acids 346 ± 371 and 1008 ± 1021, a rap1GAP homology domain spanning amino acids 1499 ± 1689 and a rabaptin-binding domain at amino acids 1668 ± 1726 (The European Chromosome 16 Tuberous Sclerosis Consortium, 1993; Xiao et al., 1997; Maheshwar et al., 1997) . As mentioned, tuberin possess GAP activity for the GTPase Rap1a (Wienecke et al., 1995) . Furthermore, mutation analysis of the rap1GAP related domain in tuberous sclerosis patients led to the characterization of disease associated mutations including missense mutations that were shown to occur as de novo mutations in sporadic TSC cases (Maheshwar et al., 1997) . Accordingly, we considered missense mutations within the GAP homologous domain to be optimal to address the question whether naturally occurring mutations would disrupt the anti-proliferative capacity of tuberin. Three of such reported mutations, N1643K, N1651S and N1681K, were introduced into full-length wild-type human TSC2 cDNA by site directed mutagenesis, cloned into the mammalian expression vector pSG5 and designated 6 2/25, 6 3/5 and 6 5/2, respectively. We transiently transfected Rat-1 ®broblasts with wild-type TSC2 in pSG5, with the three missense mutant clones or with the empty expression vector as a negative control. Two days after transfection immunoblot analyses revealed that the wild-type and the dierent mutant forms of TSC2 were overexpressed to similar levels. For all presented ®gures Western blots were chosen for which the Ponceau-S staining revealed that the amount of protein loaded on each lane was about equal. This together with analysing and presenting a non-speci®c band was chosen to check loading ( Figure 1A ). After co-transfection with the pCMV-EGFP-Spectrin vector, that expresses a membrane-associated form of the green¯uorescence protein (GFP) under the control of the CMV promoter, the green emission enables transfected from untransfected cells to be separated on a¯ow cytometer. Cell cycle distributions of the transfected cells can be investigated after DNA staining. Analysing eight independent experiments, we found that transient overexpression of wild-type tuberin in logarithmically growing Rat-1 cells lead to an increase of the proportion of G0/G1 cells (from 40.0+7.4% to 50.1+7.7%), accompanied by a decline in S phase cells (from 48.4+10.1% to 35.4+6.1%) ( Figure 1B ,C). To evaluate the signi®cance of these dierences statistical analysis using the Wilcoxon Signed Rank Test was performed. In this test P values lower than 0.04 re¯ect statistical signi®cance. The P value for the dierences in the amount of G0/G1 cells was 0.0078 for the dierences in S phase cells P=0.0117. Surprisingly, overexpression of the three dierent mutant clones also triggered eects in logarithmically growing cells ( Figure 1B,C) . In no case did the control cells show an increase in the G1 fraction or a decline in the S phase fraction relative to overexpression of TSC2 cDNAs (the P values for the dierences in G0/G1 cells compared to the control experiments were 0.0039, 0.0039, 0.0039 for the mutants 6 2/25, 6 3/5 and 6 5/2, respectively. For the dierences in S phase cells P(62/25)=0.0273, P(63/ 5)=0.0117, P(65/2)=0.0078). Assuming that the main targets of overexpressed tuberin are the G0/G1 phase and the S phase of the mammalian cell cycle one would expect that in cell populations harboring already higher numbers of G0/G1 cells the potential of tuberin to increase the number of G0/G1 cells would be lower. Six independent transfections of Rat-1 cells grown under density-restricted growth conditions harboring about 53% G0/G1 cells demonstrated that TSC2 and the three mutant clones induce weaker eects on the G0/G1-S phase distribution (data not shown).
To exclude the possibility that overexpressed TSC2 mutants mediate their anti-proliferative eects via overactivation of the endogenous wild-type tuberin we analysed tuberin-negative ®broblasts. Rat ®bro-blasts derived from Eker rat embryos homozygous for the Eker mutation (a rearrangement in the rat homolog of TSC2; Yeung et al., 1994; Kobayashi et al., 1995) were transiently transfected as described above for Rat-1 cells. As shown by immunoblot analysis these cells do not express endogenous tuberin. Overexpression levels of wild-type TSC2 and of the three mutants were comparable ( Figure 2A ). Investigation of DNA distributions on the¯ow cytometer revealed that transient transfection of wild-type TSC2 triggers an increase in the proportion of G0/G1 cells from 41.6+9.4% to 54.9+5.1%, accompanied by a decrease of S phase cells from 50.6+11.5% to 36.1+3.7%. Very similar eects could be detected after overexpression of the missense TSC2 mutants as concluded from 10 independent experiments ( Figure 2B ) (for the dierences in G0/G1 phase cells compared to the control P(wild-type)=0.0029, P(6 2/25)=0.001, P(6 3/5)= 0.0029, P(6 5/2)=0.001; for the dierences in the amount of S phase cells P(wild-type)=0.001, P(6 2/25)=0.001, P(6 3/5)=0.0033, P(6 5/2)=0.0049). Again, in no case did the control cells show an increase in the G1 fraction or a decline in the S phase fraction relative to overexpression of TSC2 cDNAs. Twelve independent transfections of tuberin negative cells under density-restricted growth conditions demonstrated that all analysed TSC2 cDNAs mediate weaker eects on the G0/G1-S phase distribution (e.g. for wild-type TSC2: from 69.2+7.3 to 77.8+8.6% G0/G1 cells and from 27.8+7.8 to 18.7+8.5% S phase cells) (data not shown). Although the immortalized Rat-1 cell line, which is tuberin positive but harbors other genetic alterations responsible for immortalization, and the tuberin negative Eker rat cells have comparable DNA distributions when transfected with the empty Oncogene Tuberous sclerosis causing TSC2 mutants maintain anti-proliferative capacity T Soucek et al control vector, the eects of wild-type TSC2 and the three TSC2 mutants appeared to be more pronounced in Eker TSC27/7cells (compare Figures 1 and 2 ). This could be due to the totally dierent genetic background of these two cell lines. But one could also speculate that ectopic tuberin and the mutants can mediate stronger eects in cells depleted of normal cellular tuberin functions. In conclusion, the eects of overexpression of TSC2 cDNAs on the G0/G1-S phase distribution of logarithmically cycling cells are con- Figure 2 Transient overexpression of TSC2 cDNAs in tuberinnegative ®broblasts. The tuberin negative cells used in this study were rat ®broblasts derived from Eker rat embryos homozygous for the Eker mutation (Yeung et al., 1994; Kobayashi et al., 1995;  see also Soucek et al., 1998b) . Mammalian expression vectors, empty as negative control or harboring either full-length wild-type TSC2 cDNA or the missense mutant TSC2 cDNA clones 6 2/25, 6 3/5, or 6 5/2, all derived from tuberous sclerosis patients, were co-transfected with a GFP expression vector. (A) Immunoblot analysis of tuberin expression in the transfected cells. NB, nonspeci®c bands, which are presented to visualize the amounts of protein loaded. (B) Logarithmically growing cells were transfected and GFP-positive cells were cyto¯uorometrically analysed for distribution of cells in dierent cell cycle phases (means+stan-dard deviations of 10 independent experiments are shown). For details of the experimental procedures see Figure 1 Figure 1 Transient overexpression of TSC2 cDNAs in Rat-1 cells. Transfections were performed using the empty mammalian expression vector pSG5, pSG5 harboring full-length wild-type human TSC2, pSG5 harboring the TSC2 GAP-domain missense mutant 6 2/25 (C to G at nucleotide 4947=Asn to Lys at amino acid 1643), the TSC2 missense mutant 6 3/5 (A to G at nucleotide 4970=Asn to Ser at amino acid 1651), and the TSC2 missense mutant 6 5/2 (C to G at nucleotide 5061=Asn to Lys at amino acid 1681). To analyse transient transfections on the¯ow cytometer cells were co-transfected with the GFP-spectrinexpression vector described in (Kalejta et al., 1997) . Cell transfections were performed either using the LipofectAMINE reagent obtained from Life Technologies (Gibco BRL, Lofer, Austria) following the transfection protocol provided by the manufacturer or following the standard protocol for calcium phosphate-mediated transfection of adherent cells (Sambrook et al., 1989) . (A) Immunoblot analysis of tuberin expression in Rat-1 transfectants. NB, non-speci®c bands, which are presented to visualize the amounts of protein loaded. Protein extraction and Western blot analyses were performed as described earlier (Miloloza et al., 2000) . Blots were stained with Ponceau-S to visualize the loaded protein. Immunodetection was performed using the anti-tuberin antibody 5063 (Wienecke et al., 1995) . Signals were detected using the enhanced chemiluminescence method (Amersham, Little Chalfont, UK). (B) FACS-DNA pro®les of GFP-positive Rat-1 cells from a representative transfection experiment performed as described above. For cyto¯uorometric analyses, cells were harvested by trypsinization and ®xed by rapid submersion in ice-cold 85% ethanol. After 1 h ®xation at 7208C, cells were pelleted and DNA was stained in 1 ml of staining solution (0.25 mg/ml propidium iodide, 0.05 mg/ ml RNase, 0.1% Triton X-100 in citrate buer, pH 7.8). Tuberous sclerosis causing TSC2 mutants maintain anti-proliferative capacity T Soucek et al sistent with the previously reported eects seen after modulation of TSC gene expression (Soucek et al., 1997 (Soucek et al., , 1998b Miloloza et al., 2000) . Furthermore, these eects are comparable to those seen after overexpression of other tumor suppressor genes involved in familial cancer syndromes. For example, 3 days of transient overexpression of BRCA1 in logarithmically growing cells triggers an increase of G0/G1 cells from about 55 to 68% accompanied by a decrease of S phase cells from about 18 to 10% (Aprelikova et al., 1999) . Modulated expression of cyclin E, that is known to directly regulate the cell cycle machinery, also mediates similar eects: 2 days of transient overexpression of cyclin E in logarithmically growing Rat-1 cells induces a 16% decrease of G0/G1 cells accompanied by a 13% increase of S phase cells (Ohtsubo and Roberts 1993) . We next sought con®rmation of these ®ndings using a dierent approach. The anti-proliferative eects of the TSC2 cDNAs were therefore tested by selection for ectopic overexpression followed by cell counting. This approach has previously demonstrated that high levels of ectopic TSC1 and TSC2 attenuate cell proliferation/ cell cycling (Jin et al., 1996; Orimoto et al., 1996; Soucek et al., 1998b; Miloloza et al., 2000; Benvenuto et al., 2000) . We transfected Rat-1 cells with the empty expression vector, with wild-type TSC2 and with the GAP-domain missense TSC2 mutant clones 6 3/5 and 6 5/2 and co-transfected with the empty pcDNA3 vector to enable G418 selection for transfected cells. Levels of overexpression of TSC2 proteins were always comparable (compare also Figure 1A) . Starting with equal cell numbers the cell pools were further kept under selection and cell numbers were determined at day 8 by counting using a hemocytometer. We found Rat-1 cells expressing wild-type TSC2 to grow signi®cantly more slowly than those containing only the empty vector. In agreement with the data described above, the TSC associated mutations did not elliminate the anti-proliferative eects of tuberin (Figure 3) .
One level of regulation of cyclin-dependent kinases, which are key regulators of the mammalian cell cycle, is provided by inhibitors. Two families of these inhibitors have been described, those that interact with a wide range of cyclin/Cdk complexes, including p21, p27 and p57, and those that only inhibit Cdk4 and Cdk6, including p15, p16, p18 and p19 (reviewed in e.p. HengstschlaÈ ger et al., 1999) . It has been shown that TSC2 aects the expression of the cyclindependent kinase inhibitor p27 (Soucek et al., 1998b; Pasumarthi et al., 2000) . Ectopic overexpression of TSC2 in tuberin-positive and in tuberin-negative cells triggers upregulation of endogenous p27 protein expression (Soucek et al., 1998b) . Western blot analyses after transient transfections revealed that introducing TSC associated mutations into wild type TSC2 cDNA does not disrupt the capacity to upregulate p27 expression in Rat1 cells as well as in Eker rat derived tuberin negative cells (Figure 4 ).
In conclusion, we demonstrate that overexpression of three independent missense mutations within TSC2, all Figure 3 Selection for ectopic overexpression of TSC2 cDNAs in Rat-1 cells. Mammalian expression vectors, empty as negative control or harboring either full length wild-type TSC2 cDNA or the missense mutant TSC2 cDNA clones 6 3/5 or 6 5/2, were transfected into Rat-1 cells. Selection for transfected cells was enabled by co-transfection with the G418-selectable vector pcDNA3. Selection was started 24 h after transfection. During the ®rst 2 days of selection the G418 concentration was 700 mg/ ml, thereafter the G418 concentration was set at 1500 mg/ml. The selected cell pools were then analysed for cell doubling rates by performing cell counting using a hemocytometer. Cell numbers determined at day 8 of such experiments are given as a percentage relative to the highest value, set as 100% (means+standard deviations of two independent experiments are shown) Figure 4 Overexpression of the naturally occurring TSC2 mutants triggers upregulation of p27 protein expression. Empty expression vector as control, wild-type TSC2 and the TSC2 mutants were transiently overexpressed in Rat-1 ®broblasts (A) and in tuberin-negative cells (B). Two days after transfection p27 protein expression was studied by Western blot analyses using the anti-p27 antibody C-19 (Santa Cruz Biotechnology). NB, nonspeci®c bands, which are presented to visualize the amounts of protein loaded Oncogene Tuberous sclerosis causing TSC2 mutants maintain anti-proliferative capacity T Soucek et al proven to be disease causing, neither eliminate the antiproliferative eects of tuberin in speci®c mammalian cells nor does it disrupt tuberin's capacity to induce p27 expression. Data were obtained using two dierent experimental approaches and analysing tuberin positive and tuberin negative cells. Earlier reported overexpression experiments have demonstrated that other mutations within TSC genes can disrupt their antiproliferative capacity (Miloloza et al., 2000) . Accordingly, overexpression experiments as performed in this study are suitable to test mutations for their capacity to disrupt the anti-proliferative eects of tuberin. However, a diculty is that in vitro assays always represent a only simpli®ed model for proliferation control in vivo. Therefore, we recognize, that negative in vitro data can not totally rule out a role for proliferation control in the TSC patient. It is important to analyse cells or cell lines derived from hamartomas of patients. Since the TSC2 mutations investigated in the presented study all map within the GAP homologous domain our data suggest that this region is not prominently involved in the regulation of proliferation. During the review process of this manuscript another report described the eects of overexpression of another natural occurring GAP-mutant of TSC2 in proliferation assays. Only 24 h after transient overexpression of a Y1571H mutant, the number of Cos1 cells and protein concentration (compaired to control vector transfections) was reduced 20 and 27%, respectively. Although under the conditions of these experiments wild-type TSC2 induced a signi®cantly stronger eect (about 50%), these data also demonstrate that the analysed natural occurring mutation can not eliminate tuberin's capacity to negatively aect cell proliferation. In this very important report, the authors found phosphorylation to be an additional level of regulation of tuberin's functions. They demonstrated for the ®rst time, that tuberin is phosphorylated at serine and tyrosine residues. This process is altered by the Y1571H mutation, what is suggested to be the reason for the signi®cant reduction in anti-proliferative capacity (Aicher et al., 2001) . Whether the mutations analysed in the here presented study alter tuberin's phosphorylation status is currently not tested. It was earlier reported that a TSC2 cDNA clone encoding only the C-terminus of tuberin (amino-acids 1049 ± 1809) was capable of reducing proliferation measured in a colony formation assay and in vivo tumorigenicity when overexpressed in Eker rat tumor cells (Jin et al., 1996) . These data suggest that only speci®c regions of tuberin are necessary for its eects on proliferation. It will be of great interest to investigate other regions of tuberin to enable a better understanding of how this protein in¯uences cell proliferation control. However, since all mutations analysed in this study were derived from TSC patients and were proven to be disease causing, our data provide strong evidence that neither deregulation of proliferation nor deregulated p27 expression represent the primary/only mechanism of hamartoma development in TSC.
